| Justice Gerald Sheridan Pilgrim, DDS | |
|
6455 Machine Street, Bldg 2501, Aberdeen Proving Ground, MD 21005 | |
| (406) 561-0626 | |
| Not Available |
| Full Name | Justice Gerald Sheridan Pilgrim |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 6455 Machine Street, Bldg 2501, Aberdeen Proving Ground, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689007825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DEN-DEN-LIC-6024 (Montana) | Secondary |
| 1223G0001X | Dentist - General Practice | DEN-DEN-LIC-6024 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Justice Gerald Sheridan Pilgrim, DDS 6455 Machine Street, Bldg 2501, Aberdeen Proving Ground, MD 21005 Ph: (406) 561-0626 | Justice Gerald Sheridan Pilgrim, DDS 6455 Machine Street, Bldg 2501, Aberdeen Proving Ground, MD 21005 Ph: (406) 561-0626 |
News Archive
The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.
A quirk of the body clock that lures some people to sleep at 8 p.m., enabling them to greet the new day as early as 4 a.m., may be significantly more common than previously believed.
Children who have been abused are at risk of recurrence and effective prevention strategies are urgently needed, say the authors of a randomized trial published online today by The Lancet.
Lipopolysaccharide, a virulence factor produced by bacteria, is a toxin that can cause a systemic inflammation via the circulation. In a recently completed study, genetic markers were discovered which are associated with a heightened lipopolysaccharide level in the blood.
Mpex Pharmaceuticals, Inc. reported positive top line results from a Phase 2b clinical trial with Aeroquin, a novel aerosol formulation of levofloxacin delivered by an optimized Investigational eFlow Nebulizer System from PARI Pharma. In the Mpex cystic fibrosis trial, nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa in sputum after 28 days of dosing versus placebo.
› Verified 1 days ago
Dr. Allen Vakhler, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2501 Machine St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1795 | |
Dr. Georgia Grace Rogers, DMD, MPH Dentist Medicare: Not Enrolled in Medicare Practice Location: 6455 Machine Street, Apg Dental Clinic, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1795 | |
Joseph A Marino, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Usa Dental Clinic Command, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1795 Fax: 410-278-1792 | |
Laura Clark, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 6455 Machine Street, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1795 |